Effect of a multitarget therapy with prednisolone, mycophenolate mofetil, and tacrolimus in a patient with type B insulin resistance syndrome complicated by lupus nephritis.

MLA

Temmoku, Jumpei, et al. “Effect of a Multitarget Therapy with Prednisolone, Mycophenolate Mofetil, and Tacrolimus in a Patient with Type B Insulin Resistance Syndrome Complicated by Lupus Nephritis.” Modern Rheumatology Case Reports, vol. 6, no. 1, Jan. 2022, pp. 41–46. EBSCOhost, https://doi.org/10.1093/mrcr/rxab020.

APA

Temmoku, J., Asano, T., Saito, K., Matsumoto, H., Fujita, Y., Furuya-Yashiro, M., Matsuoka, N., Oda, A., Tanabe, H., Sato, S., Shio-Yano, K., Sasajima, T., Kiko, Y., Kobayashi, H., Watanabe, H., Shimabukuro, M., & Migita, K. (2022). Effect of a multitarget therapy with prednisolone, mycophenolate mofetil, and tacrolimus in a patient with type B insulin resistance syndrome complicated by lupus nephritis. Modern Rheumatology Case Reports, 6(1), 41–46. https://doi.org/10.1093/mrcr/rxab020

Chicago

Temmoku, Jumpei, Tomoyuki Asano, Kenji Saito, Haruki Matsumoto, Yuya Fujita, Makiko Furuya-Yashiro, Naoki Matsuoka, et al. 2022. “Effect of a Multitarget Therapy with Prednisolone, Mycophenolate Mofetil, and Tacrolimus in a Patient with Type B Insulin Resistance Syndrome Complicated by Lupus Nephritis.” Modern Rheumatology Case Reports 6 (1): 41–46. doi:10.1093/mrcr/rxab020.